Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04405089 · ClinicalTrials.gov registry record · NA
tDCS for Impulsivity and Compulsivity in Obesity
A NA study, sponsored by Minneapolis Veterans Affairs Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT04405089: Completed NA study, sponsored by Minneapolis Veterans Affairs Medical Center.
NCT04405089 is a NA study that has completed, run by Minneapolis Veterans Affairs Medical Center. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04405089, a NA study, has completed, sponsored by Minneapolis Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Even when they know it can improve health, many individuals with loss of control eating struggle when they are trying to make and sustain new health habits for weight loss and maintenance of weight loss. Impulsivity, characterized by lack of foresight and planning and excessive risk taking, and compulsivity, characterized by inability to break old habitual behaviors, may play a role in refractory obesity. The primary objective of this pilot study is to investigate the effect of a novel neuroplasticity based intervention, cognitive training coupled with transcranial direct current stimulation (tDCS), on measures of impulsivity and compulsivity in individuals with obesity.
Primary Outcome
Differences in change in Flanker Task reaction time (score at final follow-up visit minus score at baseline) between active tDCS-cognitive training and sham-cognitive training groups. NIH Flanker absolute value range: 0 to 5 seconds. Higher values represent a better outcome. In the Flanker Task, a participant is instructed to press a key in response to viewing a stimulus presented on-screen. The Reaction Time, or the amount of time in seconds between presentation of the stimulus and the respon
Interventions
- DEVICE Device: Active Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training
- DEVICE Device: Sham Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-05-03 |
| Est. Completion | 2020-06-26 |
| Phase | NA |
What the finished NCT04405089 record still lists
NCT04405089 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Device: Active Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training is the first listed.
NCT04405089 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04405089 about?
NCT04405089 is a clinical study titled "tDCS for Impulsivity and Compulsivity in Obesity". Even when they know it can improve health, many individuals with loss of control eating struggle when they are trying to make and sustain new health habits for weight loss and maintenance of weight loss. Impulsivity, characterized by lack of foresight and planning and excessive risk taking, and comp...
What is the current status of trial NCT04405089?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2018-05-03. Estimated completion is 2020-06-26.
What interventions are being tested in trial NCT04405089?
The interventions under investigation include: Device: Active Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training (DEVICE), Device: Sham Transcranial Direct Current Stimulation (tDCS) coupled with cognitive training (DEVICE).
Who is sponsoring clinical trial NCT04405089?
This trial is sponsored by Minneapolis Veterans Affairs Medical Center, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04405089's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI